Skip to content

650nm Low-level Red-light for Myopia Control and Prevention in Children

Repeated Exposure to 650nm Low-level Red-light for Myopia Control and Prevention in Children: a Randomized Controlled Trial

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05786586
Enrollment
572
Registered
2023-03-27
Start date
2023-03-26
Completion date
2026-12-31
Last updated
2024-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Brief summary

A multicenter randomized controlled trial, evaluating the efficacy and safety of 650nm low-level red-light irradiation for myopia control and prevention in children. Participants included children(aged 6 to 12 years, spherical equivalent error of 0.5D or below) who are already myopic at recruitment, and those who are of Emmetropia or low hyperopia.

Detailed description

This multicenter randomized controlled trial will be conducted in three hospitals: Beijing Tongren Hospital, and another two subcenters. The whole study will last for five years.The investigators will perform data analysis at 6 months follow-up, one-year follow-up, two-year follow-up, three-year follow-up, four-year follow-up and the end of the study. The intervention measure used will be 650 nm low-level red-light. This kind of intervention will be integrated into a headworn device. This device could be used for treatment of myopia or amblyopia, and is safe for the eyes and has been verified by the Chinese market supervision and administration department.

Interventions

650 nm low-level red-light is a kind of laser, concentrated into a beam, to repeatedly irradiate the retina

Sponsors

Beijing Children's Hospital
CollaboratorOTHER
Children's Hospital of The Capital Institute of Pediatrics
CollaboratorOTHER
Beijing Tongren Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
6 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* Children aged 6 to 12 years * The cycloplegic spherical equivalent error (SER) is -6D to 1D (\> -6D, ≤1D) in both eyes * Astigmatism of 2.5 D or less (≤2.5D) * Willing to participate in the study and sign the informed consent form

Exclusion criteria

* Using other myopia interventions or stopped using them for less than three months, including but not limited to atropine eye drops or orthokeratology lens * With anisometropia (difference in sphere between two eyes was 1.5D or greater), strabismus, or amblyopia * With refractive media opacification (keratopathy, lens opacity, etc.) * Allergy to cycloplegia drugs

Design outcomes

Primary

MeasureTime frameDescription
Change in spherical equivalent errorBaseline, six-month follow-up, one-year follow-up, two-year follow-up, three-year follow-up, four-year follow-up, five-year follow-upChildren's pupil were dilated using Mydrin-P eye drops, and then the refractive error was measured using an autorefractor. the two measurements (axial length and spherical equivalent error) will be aggregated to arrive at one reported value through the following way: axial enlongation will be defined as progress in myopia, decrease in spherical equivalent error will be defined as progress in myopia too.
Change in axial lengthBaseline, six-month follow-up, one-year follow-up, two-year follow-up, three-year follow-up, four-year follow-up, five-year follow-upUse an optical biometer to measure the axial length.

Secondary

MeasureTime frameDescription
Change in steep keratometryBaseline, six-month follow-up, one-year follow-up, two-year follow-up, three-year follow-up, four-year follow-up, five-year follow-upUse an optical biometer
Change in flat keratometryBaseline, six-month follow-up, one-year follow-up, two-year follow-up, three-year follow-up, four-year follow-up, five-year follow-upUse an optical biometer
Change in anterior chamber depthBaseline, six-month follow-up, one-year follow-up, two-year follow-up, three-year follow-up, four-year follow-up, five-year follow-upUse an optical biometer
Change in central corneal thicknessBaseline, six-month follow-up, one-year follow-up, two-year follow-up, three-year follow-up, four-year follow-up, five-year follow-upUse an optical biometer
Change in length thicknessBaseline, six-month follow-up, one-year follow-up, two-year follow-up, three-year follow-up, four-year follow-up, five-year follow-upUse an optical biometer
Change in Choroid thicknessBaseline, six-month follow-up, one-year follow-up, two-year follow-up, three-year follow-up, four-year follow-up, five-year follow-upUse an enhanced-depth imaging technique (based on Optical coherence tomography )

Other

MeasureTime frameDescription
Fundus injury related to 650 nm low-level red-light irridiationBaseline, six-month follow-up, one-year follow-up, two-year follow-up, three-year follow-up, four-year follow-up, five-year follow-upAny potential fundus injury related to 650 nm low-level red-light irridiation would be checked through Fundus photography and coherence tomography examination

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026